secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACADIA PHARMACEUTICALS INC (ACAD)
CIK:        0001070494
Form:       8-K
Filed at:   2025-11-03T23:59:59+00:00
Accession:  0001193125-25-262610
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Daniel B. Soland resigns from Acadia board and governance committee chair
--------------------------------------------------------------------------------

- Resignation effective October 30, 2025.
- Mr. Soland stepped down from the Board and as Chair of Nominating and Corporate Governance Committee.
- Resignation not due to any dispute or disagreement with the Company or Board.
- No replacement for the Board seat or committee chair has been announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1070494/000119312525262610/0001193125-25-262610-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1070494/000119312525262610/acad-20251028.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-262610

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer